Results 291 to 300 of about 2,098,172 (396)
Right Heart Failure-Unrecognized Cause of Cardiorenal Syndrome.
S. Bansal, Anand Prasad, S. Linas
semanticscholar +1 more source
The biomimetic nanoplatform IMNP (ETS1 pDNA/PBAE@ITP‐MM) undergoes targeted disassembly at inflammatory vascular sites to release the ETS1 plasmid (pETS1). This release initiates a cascade of effects that inhibit pathogenic pathways and support immune homeostasis. (Abbreviations: EndMT, endothelial‐to‐mesenchymal transition; EC, endothelial cell; TC, T
Feng Zhang +13 more
wiley +1 more source
Fontan operation for severe right heart failure with protein-losing enteropathy for a child with left ventricular assist device. [PDF]
Yoshida H +6 more
europepmc +1 more source
Development and validation of a prognostic risk model for pediatric patients with left-to-right shunt congenital heart disease and heart failure [PDF]
Li Mei Zhang +3 more
openalex +1 more source
Ferritin‐doped hybrid nanoparticles triggered accurate tumor‐specific hemorrhage for enhanced in situ photothermal therapy and evoked anti‐tumor immunity. Notably, HFn/GA‐Fe specifically induced tumor hemorrhage 12 h after intravenous injection, resulting in visible color darkening. Through photoacoustic imaging, tumor vessels could be clearly observed
Haidong Zha +7 more
wiley +1 more source
Graded response of the pulmonary circulation to progressive pulmonary embolism in sheep: From compensation to lethal right heart failure. [PDF]
Zhou C +7 more
europepmc +1 more source
This review explores how alternative invertebrate and small‐vertebrate models advance the evaluation of nanomaterials across medicine and environmental science. By bridging cellular and organismal levels, these models enable integrated assessment of toxicity, biodistribution, and therapeutic performance.
Marie Celine Lefevre +3 more
wiley +1 more source
Outcomes following isolated right ventricular assist device as durable support for primary right heart failure: An INTERMACS analysis. [PDF]
Birati EY +18 more
europepmc +1 more source

